Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Integrated Diagnostics Holdings ( (GB:IDHC) ) has issued an update.
Integrated Diagnostics Holdings (IDH) reported a significant 42% revenue growth in the first half of 2025, driven by a 10% increase in test volumes and a 29% rise in average revenue per test. The company’s gross profit expanded by 61% and its adjusted EBITDA increased by 78%, reflecting improved cost management and operational efficiency. A strategic acquisition of CAIRO RAY for Radiotherapy by IDH’s subsidiary, Al Borg Scan, marks a pivotal step in enhancing its radiology services, aligning with its long-term vision. This acquisition, along with the company’s robust financial performance, positions IDH strongly within the diagnostic services industry, promising potential benefits for stakeholders.
More about Integrated Diagnostics Holdings
Integrated Diagnostics Holdings (IDH) is a leading provider of diagnostic services operating in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The company specializes in offering a wide range of pathology and radiology services, with a strong market presence and focus on expanding its branch network and service offerings.
Average Trading Volume: 520,153
Technical Sentiment Signal: Hold
Current Market Cap: $283.1M
Find detailed analytics on IDHC stock on TipRanks’ Stock Analysis page.